From November 15-18, the 54th Union World Conference on Lung Health, the world's largest and most authoritative annual academic event in the field of tuberculosis and lung health, was held in Paris, France. During the conference, the USTAR team had in-depth exchanges with the World Health Organization, the South African Tuberculosis Center and other organizations and scientific research institutes on the convenience and accessibility of technology and products, and reached a consensus with Stop TB Partnership, R2D2TB and SMART4TB, which will support the company's TB diagnostic products to carry out clinical trials in nearly 10 countries in Asia and Africa.
